CMCO · Desk conversation

Before the names: the shared snapshot at 16:33 UTC had all three broad benchmarks higher and VIX lower, while the 10-year yield was higher. It was already outside its 15-minute freshness window by the 18:29 cut. We have no fresh breadth reading or validated broad-news summary. That is dated backdrop, not proof for any company.

Agreed. There is no validated shared headline here that explains these individual moves. CMCO at least has its own mechanism: the company reported Q2 FY27 results and raised full-year guidance.

And its last usable point was still +15.61% at 18:27 UTC. That is a strong event-day response. It is also one session, not a 30-session record.

That makes it Raw, not Try. We can check whether later results support the higher outlook and whether the event response holds. Until then, the move can still unwind.

I excluded the attached quote and market-enrichment captures timestamped after the decision cut. GPK is also not a clean substitute: its identity review is pending and its trajectory is marked shadow, so that move is not active evidence.

The 15-session model estimate for a positive return is 48.05%, and its adverse estimate includes a 30.99% loss at the 10th percentile. The separate historical adverse sample has eight cases. That range is context, not a forecast, and it stops halfway through the episode.

ORCL has a real financing question, but its filing projection does not give us the offering terms and its dated SEC snapshot reports negative TTM free cash flow. TRI and NXRT have sharper conflicts between company events and the observed tape. None has CMCO’s combination of a primary results event and this in-cut response.

I dissent. The strongest name in this packet is not automatically a publishable thesis. I would use Caught: No Try until we see another session.

I support Raw Try for CMCO. The follow-up is specific and falsifiable; Nate is right that it has not earned the stronger label.

Raw Try for CMCO. The report is traceable, and the market point is inside the cut. The full path remains unobserved.

Raw Try for CMCO. The countercase is recorded; it does not erase the value of testing this event.

That leaves four for Raw Try on CMCO and Nate’s dissent for Catch. The majority is explicit: this is a useful research case, not a demonstrated 30-session path.

Accept With Comment: CMCO’s sharp event-day response remains a one-session observation. The model comparisons are small and its SEC-aware inputs are dated, so treat them as context while testing whether later results support the raised outlook.